Theraclion specializes in developping, manufacturing and marketing echotherapy equipment associating therapy with focused ultrasound (HIFU) and monitoring by ultrasound. The company provides Echopulse, a device for non-invasive and outpatient treatment of mammary fibroadenoma and thyroid nodules.Net sales break down by activity as follows: - sale of consumables (52.8%); - sale of equipment (28.8%); - provision of after-sales services (18.4%). The vast majority of net sales are earned abroad.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change
16/26/16	€0.6700	0.00%
15/26/15	€0.6700	-1.33%
14/26/14	€0.6790	+1.04%
13/26/13	€0.6720	0.00%
10/26/10	€0.6720	+1.82%

Real-time BOERSE MUENCHEN

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Real-time BOERSE MUENCHEN Other stock markets 11:13:53 16/07/2026 pm IST			5-day change	1st Jan Change
0.6700 ^EUR	0.00%		+1.82%	+14.73%

09/07	Theraclion Announces Board Changes	CI
09/07	Theraclion Appoints New Chairman	MT

Market Cap	4.9Cr 5.6Cr 4.53Cr 4.16Cr 7.87Cr 539.98Cr 8Cr 54Cr 21Cr 263.69Cr 21Cr 21Cr 910.36Cr	P/E 2024	-2.66x	P/E 2025	-6.33x
Enterprise Value	5.68Cr 6.5Cr 5.26Cr 4.82Cr 9.13Cr 626.54Cr 9.29Cr 63Cr 25Cr 305.96Cr 24Cr 24Cr 1.06TCr	EV / Sales 2024	22.5x	EV / Sales 2025	55.4x
Free-Float	54.37%	Yield 2024 *	-	Yield 2025	-

09/07	Theraclion Announces Board Changes	CI
09/07	Theraclion Appoints New Chairman	MT
19/06	Claude Lenoir appointed interim chairman of Theraclion
19/06	Theraclion Chairman Steps Down; Interim Successor Named	MT
18/06	Theraclion Announces Board Changes	CI
09/06	Theraclion Secures AMA CPT Editorial Panel Approval For New Category III CPT Code For Sonovein	CI
05/06	Theraclion deploys first Sonovein system in China
05/06	Theraclion JV Deploys Sonovein System at Chinese Hospital	MT
05/06	Theraclion Announces First Clinical Deployment Of Sonovein In Hainan, China	CI
05/06	Theraclion Deploys Sonovein System At Boao Super Hospital in Hainan Province	CI
01/06	Theraclion Presents Promising Preliminary Results From Sonovein SpeedPulse At First International HIFU Congress	CI
11/05	Bouygues, Euronext, Vallourec... stocks to watch today in Paris
11/05	Theraclion raises nearly 6 million euros via units with warrants

15/07	Theraclion: First Half 2026 Report on the Liquidity Contract With CRÉDIT INDUSTRIEL ET COMMERCIAL	BU
09/07	Theraclion Strengthens Its Governance by Appointing Vincent Gardès as Chairman of Its Board of Directors	BU
18/06	Theraclion Announces the Evolution of Its Board of Directors	BU
08/06	Theraclion Secures Key U.S. Reimbursement Milestone for Sonovein® With AMA CPT Editorial Panel Approval of a New Category III CPT Code	BU
04/06	Theraclion Announces First Clinical Deployment of Sonovein® in Hainan, China	BU

Theraclion Share Price BOERSE MUENCHEN

Stocks

941

FR0010120402

Advanced Medical Equipment & Technology

Valuation: Theraclion

Chart: Theraclion

Latest news : Theraclion

Press Releases: Theraclion

News in other languages: Theraclion

Quotes and Performance

Course Extremes

Managers and Directors: Theraclion

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

15/07	Theraclion: BILAN DU PREMIER SEMESTRE 2026 DU CONTRAT DE LIQUIDITÉ CONTRACTÉ AVEC LE CRÉDIT INDUSTRIEL ET COMMERCIAL
09/07	Vincent Gardès prend la présidence du conseil d'administration de Theraclion
09/07	THERACLION RENFORCE SA GOUVERNANCE EN NOMMANT VINCENT GARDÈS À LA PRÉSIDENCE DE SON CONSEIL D'ADMINISTRATION
19/06	Bourse : Crédit Agricole veut jouer un rôle en Italie, 2CRSi va communiquer
19/06	Les puces américaines en weekend prolongé

Current month	-21.18%
3 months	+45.97%
6 months	+12.79%
Current year	+14.73%

Current year	0.44	0.87
1 year	0.36	0.94
3 years	0.14	0.94
5 years	0.14	0.94
10 years	0.14	0.94

Manager	Title	Age	Since
Martin Deterre CEO	Chief Executive Officer	-	24/05/2023
Julie Veisseire DFI	Director of Finance/CFO	-	-
Alexandra Rocher COO	Chief Operating Officer	-	-

Director	Title	Age	Since
Renaud Saleur BRD	Director/Board Member	-	01/02/2018
Ari Kellen BRD	Director/Board Member	-	13/02/2019
Shawn Langer BRD	Director/Board Member	-	13/02/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
THERACLION	0.00%	+1.82%	-	-	5.6Cr
THERMO FISHER SCIENTIFIC, INC.	+0.44%	+2.48%	+29.17%	+2.38%	20TCr
DANAHER CORPORATION	+0.91%	+3.52%	+4.96%	-14.67%	14TCr
INTUITIVE SURGICAL, INC.	+2.69%	-3.29%	-22.36%	+12.48%	14TCr
BOSTON SCIENTIFIC CORPORATION	+4.36%	-0.68%	-56.70%	-15.06%	6.4TCr
EDWARDS LIFESCIENCES CORPORATION	+0.52%	-4.47%	+14.58%	-5.83%	5.03TCr
SIEMENS HEALTHINEERS AG	+1.18%	+2.27%	-23.75%	-31.73%	4.43TCr
AGILENT TECHNOLOGIES, INC.	-0.29%	+0.57%	+18.44%	+13.62%	3.8TCr
WATERS CORPORATION	+0.33%	-0.19%	+29.99%	+39.49%	3.68TCr
GE HEALTHCARE TECHNOLOGIES INC.	+2.19%	-0.39%	-14.58%	-20.62%	2.87TCr
Average	+1.24%	-0.50%	-2.25%	-2.22%	8.23TCr
Weighted average by Cap.	+1.43%	+0.18%	+1.17%	-1.59%

	2024	2025
Net sales	8L 9L 8L 7L 13.33L 9.15Cr 13.57L 91.56L 35.97L 4.47Cr 35.67L 34.88L 15Cr	7L 7L 6L 6L 10.47L 7.19Cr 10.65L 71.91L 28.25L 3.51Cr 28.01L 27.4L 12Cr
Net income	-57.57L -65.86L -53.24L -48.86L -92.47L -63Cr -94.07L -6.35Cr -2.49Cr -31Cr -2.47Cr -2.42Cr -107Cr	-56.9L -65.1L -52.62L -48.29L -91.39L -63Cr -92.98L -6.28Cr -2.47Cr -31Cr -2.44Cr -2.39Cr -105.75Cr
Net Debt	34.11L 39.02L 31.54L 28.94L 54.78L 38Cr 55.73L 3.76Cr 1.48Cr 18Cr 1.47Cr 1.43Cr 63Cr	78.52L 89.83L 72.62L 66.63L 1.26Cr 87Cr 1.28Cr 8.66Cr 3.4Cr 42Cr 3.37Cr 3.3Cr 145.93Cr